ALZCHEM GROUP AG INH O.N.
ALZCHEM GROUP AG INH O.N./ DE000A2YNT30 /
ACT/D
23/01/2025 18:30:40
|
Var.
+0.60
|
Volume |
Denaro18:31:57 |
Lettera18:31:57 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
64.80EUR
|
+0.93%
|
3,048 Fatturato: 195,475.60 |
64.40Quantità in denaro: 50 |
64.80Quantità in lettera: 50 |
659.43 mill.EUR |
1.62% |
19.06 |
Descrizione business
AlzChem AG, located in Trostberg, Bavaria, is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding, which are used in a variety of industries. The company has a leading market position in selected niche markets, including the markets for feed additives and food supplements. The strategic focus of growth and the focus of the extensive research and development lie on the business segment Specialty Chemicals. The joint production and the brand portfolio protect AlzChem from potential market entries.
Consiglio di amministrazione & Consiglio di sorveglianza
CEO |
Andreas Lösler |
Consiglio di amministrazione |
Andreas Niedermaier, Klaus Englmaier, Dr. Georg Weichselbaumer |
Consiglio di sorveglianza |
Markus Zöllner, Prof. Dr. Martina Heigl-Murauer, Steve Röper, Dr. Caspar Freiherr von Schnurbein |
Dati aziendali
Name: |
AlzChem Group AG |
Indirizzo: |
Chemiepark Trostberg, Dr.-Albert-Frank-Str. 32,D-83308 Trostberg |
Telefono: |
+49-8621-86-0 |
Fax: |
+49-8621-86-2911 |
E-mail: |
info@alzchem.com
|
Internet: |
https://www.alzchem.com/ |
Industria: |
Commodities |
Settore: |
Chemicals |
Sub settore: |
Chemicals, diversified |
Fine dell'anno finanziario: |
31/12 |
Flottante libero: |
50.35% |
Data dell'IPO: |
01/06/1999 |
Rapporti con gli investitori
Name: |
Sabine Sieber |
IR telefono: |
+49-8621-86-2888 |
IR Fax: |
- |
IR e-mail: |
ir@alzchem.com
|
Company calendar
CW 9 | 28/02/2025
4th Quarter/Annual Report
|
CW 18 | 30/04/2025
Interim Report 1st Quarter/3 Months
|
CW 31 | 30/07/2025
Interim Report 2nd Quarter/6 Months
|
CW 44 | 30/10/2025
Interim Report 3rd Quarter/9 Months
|